Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
63
Number of overlapping holdings
100.0%
% of XLV's 64 holdings also in IXJ
58.3%
% of IXJ's 113 holdings also in XLV
Overlap by Weight
Sector Drift (XLV minus IXJ)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XLV |
Weight in IXJ |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 11.2% | 8.1% | 8.1% |
|
UNITEDHEALTH GROUP INC | 9.0% | 6.5% | 6.5% |
|
JOHNSON & JOHNSON | 6.9% | 4.7% | 4.7% |
|
MERCK & CO. INC. | 6.2% | 4.5% | 4.5% |
|
ABBVIE INC | 5.7% | 4.1% | 4.1% |
Position Highlights (Non-Overlapping Exposures)
XLV Overweight Relative to IXJ
|
ELI LILLY & CO | 3.1% |
|
UNITEDHEALTH GROUP INC | 2.5% |
|
JOHNSON & JOHNSON | 2.2% |
|
MERCK & CO. INC. | 1.7% |
|
ABBVIE INC | 1.6% |
|
THERMO FISHER SCIENTIFIC INC | 1.1% |
|
ABBOTT LABORATORIES | 1.0% |
|
DANAHER CORP | 0.8% |
|
PFIZER INC | 0.8% |
|
AMGEN INC | 0.8% |
XLV Underweight Relative to IXJ
 |
NOVO NORDISK A/S-B | -5.6% |
 |
ASTRAZENECA PLC | -2.9% |
 |
NOVARTIS AG | -2.7% |
|
ROCHE HOLDING LTD | -2.4% |
 |
SANOFI-AVENTIS | -1.4% |
 |
CSL LIMITED | -1.2% |
|
ESSILOR INTERNATIONAL | -0.9% |
 |
DAIICHI SANKYO CO LTD | -0.8% |
|
TAKEDA PHARMACEUTICAL CO LTD | -0.6% |
|
LONZA GROUP AG-REG | -0.6% |